The ARCHS4 kinase analysis showed an enrichment of several cell cycle kinases genes such as CDK1, BUB1, AURKB, PBK, MELK, BUB1B, MASTL, PLK4, TKK, and PLK1 (Figure 2b), which constitute therapeutic targets for cancers [77]. This evidence concerns the gene PLK4 and cancer.